Gene-based Advanced Therapy Medical Product Market, Global Outlook and Forecast 2022-2028

February 2022 | 66 pages | ID: G5E42C89E8F6EN
Market Monitor Global

Abstracts

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

This report contains market size and forecasts of Gene-based Advanced Therapy Medical Product in Global, including the following market information:

Global Gene-based Advanced Therapy Medical Product Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Gene-based Advanced Therapy Medical Product market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Viral Gene Delivery System Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gene-based Advanced Therapy Medical Product include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene-based Advanced Therapy Medical Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gene-based Advanced Therapy Medical Product Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Gene-based Advanced Therapy Medical Product Market Segment Percentages, by Type, 2021 (%)

• Viral Gene Delivery System
• Non-viral Gene Delivery System

Global Gene-based Advanced Therapy Medical Product Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Gene-based Advanced Therapy Medical Product Market Segment Percentages, by Application, 2021 (%)

• Neurological Diseases
• Cancer
• Other

Global Gene-based Advanced Therapy Medical Product Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Gene-based Advanced Therapy Medical Product Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gene-based Advanced Therapy Medical Product revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Gene-based Advanced Therapy Medical Product revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Biogen
• Novartis
• Gilead Sciences
• Sarepta Therapeutics
• Alnylam Pharmaceuticals
• Amgen
• Spark Therapeutics
• Akcea Therapeutics
• bluebird bio
• Sunway Biotech
• SIBIONO
• AnGes
• Orchard Therapeutics
• Human Stem Cells Institute

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gene-based Advanced Therapy Medical Product Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gene-based Advanced Therapy Medical Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENE-BASED ADVANCED THERAPY MEDICAL PRODUCT OVERALL MARKET SIZE

2.1 Global Gene-based Advanced Therapy Medical Product Market Size: 2021 VS 2028
2.2 Global Gene-based Advanced Therapy Medical Product Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gene-based Advanced Therapy Medical Product Players in Global Market
3.2 Top Global Gene-based Advanced Therapy Medical Product Companies Ranked by Revenue
3.3 Global Gene-based Advanced Therapy Medical Product Revenue by Companies
3.4 Top 3 and Top 5 Gene-based Advanced Therapy Medical Product Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gene-based Advanced Therapy Medical Product Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene-based Advanced Therapy Medical Product Players in Global Market
  3.6.1 List of Global Tier 1 Gene-based Advanced Therapy Medical Product Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gene-based Advanced Therapy Medical Product Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gene-based Advanced Therapy Medical Product Market Size Markets, 2021 & 2028
  4.1.2 Viral Gene Delivery System
  4.1.3 Non-viral Gene Delivery System
4.2 By Type - Global Gene-based Advanced Therapy Medical Product Revenue & Forecasts
  4.2.1 By Type - Global Gene-based Advanced Therapy Medical Product Revenue, 2017-2022
  4.2.2 By Type - Global Gene-based Advanced Therapy Medical Product Revenue, 2023-2028
  4.2.3 By Type - Global Gene-based Advanced Therapy Medical Product Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gene-based Advanced Therapy Medical Product Market Size, 2021 & 2028
  5.1.2 Neurological Diseases
  5.1.3 Cancer
  5.1.4 Other
5.2 By Application - Global Gene-based Advanced Therapy Medical Product Revenue & Forecasts
  5.2.1 By Application - Global Gene-based Advanced Therapy Medical Product Revenue, 2017-2022
  5.2.2 By Application - Global Gene-based Advanced Therapy Medical Product Revenue, 2023-2028
  5.2.3 By Application - Global Gene-based Advanced Therapy Medical Product Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gene-based Advanced Therapy Medical Product Market Size, 2021 & 2028
6.2 By Region - Global Gene-based Advanced Therapy Medical Product Revenue & Forecasts
  6.2.1 By Region - Global Gene-based Advanced Therapy Medical Product Revenue, 2017-2022
  6.2.2 By Region - Global Gene-based Advanced Therapy Medical Product Revenue, 2023-2028
  6.2.3 By Region - Global Gene-based Advanced Therapy Medical Product Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gene-based Advanced Therapy Medical Product Revenue, 2017-2028
  6.3.2 US Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.3.3 Canada Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.3.4 Mexico Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gene-based Advanced Therapy Medical Product Revenue, 2017-2028
  6.4.2 Germany Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.4.3 France Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.4.4 U.K. Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.4.5 Italy Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.4.6 Russia Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.4.7 Nordic Countries Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.4.8 Benelux Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gene-based Advanced Therapy Medical Product Revenue, 2017-2028
  6.5.2 China Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.5.3 Japan Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.5.4 South Korea Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.5.5 Southeast Asia Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.5.6 India Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gene-based Advanced Therapy Medical Product Revenue, 2017-2028
  6.6.2 Brazil Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.6.3 Argentina Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gene-based Advanced Therapy Medical Product Revenue, 2017-2028
  6.7.2 Turkey Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.7.3 Israel Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.7.4 Saudi Arabia Gene-based Advanced Therapy Medical Product Market Size, 2017-2028
  6.7.5 UAE Gene-based Advanced Therapy Medical Product Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Biogen
  7.1.1 Biogen Corporate Summary
  7.1.2 Biogen Business Overview
  7.1.3 Biogen Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.1.4 Biogen Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.1.5 Biogen Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.2.4 Novartis Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Gilead Sciences
  7.3.1 Gilead Sciences Corporate Summary
  7.3.2 Gilead Sciences Business Overview
  7.3.3 Gilead Sciences Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.3.4 Gilead Sciences Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.3.5 Gilead Sciences Key News
7.4 Sarepta Therapeutics
  7.4.1 Sarepta Therapeutics Corporate Summary
  7.4.2 Sarepta Therapeutics Business Overview
  7.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.4.4 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.4.5 Sarepta Therapeutics Key News
7.5 Alnylam Pharmaceuticals
  7.5.1 Alnylam Pharmaceuticals Corporate Summary
  7.5.2 Alnylam Pharmaceuticals Business Overview
  7.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.5.4 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.5.5 Alnylam Pharmaceuticals Key News
7.6 Amgen
  7.6.1 Amgen Corporate Summary
  7.6.2 Amgen Business Overview
  7.6.3 Amgen Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.6.4 Amgen Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.6.5 Amgen Key News
7.7 Spark Therapeutics
  7.7.1 Spark Therapeutics Corporate Summary
  7.7.2 Spark Therapeutics Business Overview
  7.7.3 Spark Therapeutics Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.7.4 Spark Therapeutics Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.7.5 Spark Therapeutics Key News
7.8 Akcea Therapeutics
  7.8.1 Akcea Therapeutics Corporate Summary
  7.8.2 Akcea Therapeutics Business Overview
  7.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.8.4 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.8.5 Akcea Therapeutics Key News
7.9 bluebird bio
  7.9.1 bluebird bio Corporate Summary
  7.9.2 bluebird bio Business Overview
  7.9.3 bluebird bio Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.9.4 bluebird bio Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.9.5 bluebird bio Key News
7.10 Sunway Biotech
  7.10.1 Sunway Biotech Corporate Summary
  7.10.2 Sunway Biotech Business Overview
  7.10.3 Sunway Biotech Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.10.4 Sunway Biotech Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.10.5 Sunway Biotech Key News
7.11 SIBIONO
  7.11.1 SIBIONO Corporate Summary
  7.11.2 SIBIONO Business Overview
  7.11.3 SIBIONO Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.11.4 SIBIONO Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.11.5 SIBIONO Key News
7.12 AnGes
  7.12.1 AnGes Corporate Summary
  7.12.2 AnGes Business Overview
  7.12.3 AnGes Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.12.4 AnGes Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.12.5 AnGes Key News
7.13 Orchard Therapeutics
  7.13.1 Orchard Therapeutics Corporate Summary
  7.13.2 Orchard Therapeutics Business Overview
  7.13.3 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.13.4 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.13.5 Orchard Therapeutics Key News
7.14 Human Stem Cells Institute
  7.14.1 Human Stem Cells Institute Corporate Summary
  7.14.2 Human Stem Cells Institute Business Overview
  7.14.3 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Major Product Offerings
  7.14.4 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Revenue in Global Market (2017-2022)
  7.14.5 Human Stem Cells Institute Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gene-based Advanced Therapy Medical Product Market Opportunities & Trends in Global Market
Table 2. Gene-based Advanced Therapy Medical Product Market Drivers in Global Market
Table 3. Gene-based Advanced Therapy Medical Product Market Restraints in Global Market
Table 4. Key Players of Gene-based Advanced Therapy Medical Product in Global Market
Table 5. Top Gene-based Advanced Therapy Medical Product Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gene-based Advanced Therapy Medical Product Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gene-based Advanced Therapy Medical Product Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gene-based Advanced Therapy Medical Product Product Type
Table 9. List of Global Tier 1 Gene-based Advanced Therapy Medical Product Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene-based Advanced Therapy Medical Product Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gene-based Advanced Therapy Medical Product Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gene-based Advanced Therapy Medical Product Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gene-based Advanced Therapy Medical Product Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gene-based Advanced Therapy Medical Product Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2023-2028
Table 30. Biogen Corporate Summary
Table 31. Biogen Gene-based Advanced Therapy Medical Product Product Offerings
Table 32. Biogen Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Gene-based Advanced Therapy Medical Product Product Offerings
Table 35. Novartis Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 36. Gilead Sciences Corporate Summary
Table 37. Gilead Sciences Gene-based Advanced Therapy Medical Product Product Offerings
Table 38. Gilead Sciences Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 39. Sarepta Therapeutics Corporate Summary
Table 40. Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Product Offerings
Table 41. Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 42. Alnylam Pharmaceuticals Corporate Summary
Table 43. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Product Offerings
Table 44. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 45. Amgen Corporate Summary
Table 46. Amgen Gene-based Advanced Therapy Medical Product Product Offerings
Table 47. Amgen Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 48. Spark Therapeutics Corporate Summary
Table 49. Spark Therapeutics Gene-based Advanced Therapy Medical Product Product Offerings
Table 50. Spark Therapeutics Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 51. Akcea Therapeutics Corporate Summary
Table 52. Akcea Therapeutics Gene-based Advanced Therapy Medical Product Product Offerings
Table 53. Akcea Therapeutics Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 54. bluebird bio Corporate Summary
Table 55. bluebird bio Gene-based Advanced Therapy Medical Product Product Offerings
Table 56. bluebird bio Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 57. Sunway Biotech Corporate Summary
Table 58. Sunway Biotech Gene-based Advanced Therapy Medical Product Product Offerings
Table 59. Sunway Biotech Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 60. SIBIONO Corporate Summary
Table 61. SIBIONO Gene-based Advanced Therapy Medical Product Product Offerings
Table 62. SIBIONO Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 63. AnGes Corporate Summary
Table 64. AnGes Gene-based Advanced Therapy Medical Product Product Offerings
Table 65. AnGes Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 66. Orchard Therapeutics Corporate Summary
Table 67. Orchard Therapeutics Gene-based Advanced Therapy Medical Product Product Offerings
Table 68. Orchard Therapeutics Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)
Table 69. Human Stem Cells Institute Corporate Summary
Table 70. Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Product Offerings
Table 71. Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Gene-based Advanced Therapy Medical Product Segment by Type in 2021
Figure 2. Gene-based Advanced Therapy Medical Product Segment by Application in 2021
Figure 3. Global Gene-based Advanced Therapy Medical Product Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gene-based Advanced Therapy Medical Product Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gene-based Advanced Therapy Medical Product Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene-based Advanced Therapy Medical Product Revenue in 2021
Figure 8. By Type - Global Gene-based Advanced Therapy Medical Product Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gene-based Advanced Therapy Medical Product Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gene-based Advanced Therapy Medical Product Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gene-based Advanced Therapy Medical Product Revenue Market Share, 2017-2028
Figure 12. US Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gene-based Advanced Therapy Medical Product Revenue Market Share, 2017-2028
Figure 16. Germany Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 17. France Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gene-based Advanced Therapy Medical Product Revenue Market Share, 2017-2028
Figure 24. China Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 28. India Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gene-based Advanced Therapy Medical Product Revenue Market Share, 2017-2028
Figure 30. Brazil Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gene-based Advanced Therapy Medical Product Revenue Market Share, 2017-2028
Figure 33. Turkey Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gene-based Advanced Therapy Medical Product Revenue, (US$, Mn), 2017-2028
Figure 37. Biogen Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Gilead Sciences Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Spark Therapeutics Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Akcea Therapeutics Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. bluebird bio Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sunway Biotech Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. SIBIONO Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. AnGes Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Orchard Therapeutics Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)